Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 10/20 | 1.00 |
| ▸ | ESR2 | Q92731 | 10/20 | 1.00 |
| ▸ | HSD17B1 | P14061 | 4/20 | 0.69 |
| ▸ | HSD17B2 | P37059 | 4/20 | 0.69 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | MMP3 | P08254 | 1/20 | 0.56 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.56 |
| ▸ | ABL1 | P00519 | 1/20 | 0.56 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.56 |
| ▸ | BCR | P11274 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29672355 | 1.00 | ESR1 (1.00) | ESR1ESR2HSD17B1HSD17B2ALOX5 | |
| SCHEMBL27616561 | 0.93 | ESR1 (0.87) | ESR1ESR2HSD17B1HSD17B2ALOX5 | |
| SCHEMBL3107306 | 0.91 | ESR2 (0.83) | ESR1ESR2HSD17B1HSD17B2ALOX5 | |
| SCHEMBL14506125 | 0.91 | ESR2 (0.83) | ESR1ESR2HSD17B1HSD17B2ALOX5 | |
| SCHEMBL11978649 | 0.88 | ESR2 (0.80) | ESR1ESR2HSD17B1HSD17B2ALOX5 | |
| SCHEMBL29587268 | 0.88 | ESR2 (0.80) | ESR1ESR2HSD17B1HSD17B2ALOX5 | |
| SCHEMBL31039575 | 0.87 | ESR1 (0.76) | ESR1ESR2HSD17B1HSD17B2ALOX5 | |
| Naphthalene SCHEMBL11342178 | 0.87 | ESR1 (0.76) | ESR1ESR2HSD17B1HSD17B2CYP1A2 | |
| SCHEMBL18260181 | 0.87 | ESR1 (0.76) | ESR1ESR2HSD17B1HSD17B2ALOX5 | |
| SCHEMBL27433243 | 0.86 | ESR1 (0.76) | ESR1ESR2HSD17B1HSD17B2ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 388 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12187911-B2 | Method for preparing water-soluble acrylic-modified phenolic-modified epoxy resin, water-soluble acrylic-modified phenolic-modified epoxy resin prepared thereby, and aqueous coating composition comprising same | SAMHWA PAINTS INDUSTRIES CO., LTD. (KR) | 2025-01-07 | — | — | US | claimed |
| US-20240117213-A1 | METHOD FOR PREPARING WATER-SOLUBLE ACRYLIC-MODIFIED PHENOLIC-MODIFIED EPOXY RESIN, WATER-SOLUBLE ACRYLIC-MODIFIED PHENOLIC-MODIFIED EPOXY RESIN PREPARED THEREBY, AND AQUEOUS COATING COMPOSITION COMPRISING SAME | SAMHWA PAINTS INDUSTRIES CO., LTD. (KR) | 2024-04-11 | — | — | US | claimed |
| CN-117776963-A | Synthesis method of phenol by diazotization | 新疆大学 | 2024-03-29 | — | — | CN | claimed |
| WO-2021075800-A1 | METHOD FOR PREPARING WATER-SOLUBLE ACRYLIC-MODIFIED PHENOLIC-MODIFIED EPOXY RESIN, WATER-SOLUBLE ACRYLIC-MODIFIED PHENOLIC-MODIFIED EPOXY RESIN PREPARED THEREBY, AND AQUEOUS COATING COMPOSITION COMPRISING SAME | 삼화페인트공업주식회사 | 2021-04-22 | — | — | WO | claimed |
| CN-106831361-B | A kind of method that dihalo trifluoroethane prepares trifluoro vinyl virtue ether compound | 中昊晨光化工研究院有限公司 | 2019-06-25 | — | — | CN | claimed |
| CN-106632239-B | A kind of isolonglifolane ketone group hexahydro quinazoline -2- amine schiff's base type fluorescent material and its synthetic method and application | 南京林业大学 | 2019-04-12 | — | — | CN | claimed |
| CN-108779248-A | Benzylated Mannich base curatives, compositions, and methods | 赢创德固赛有限公司 | 2018-11-09 | — | — | CN | claimed |
| CN-108697709-A | Methods for treating huntington's disease | PTC医疗公司 | 2018-10-23 | — | — | CN | claimed |
| CN-108277514-A | A kind of preparation method of plating dehydrating agent | 常州五荣化工有限公司 | 2018-07-13 | — | — | CN | claimed |
| CN-108255014-A | A kind of dry film photoresist containing modified polyurethane and photo-curing monomer | 珠海市能动科技光学产业有限公司 | 2018-07-06 | — | — | CN | claimed |
| CN-106831361-A | A kind of method that dihalo HFC-143a prepares trifluoro vinyl virtue ether compound | 中昊晨光化工研究院有限公司 | 2017-06-13 | — | — | CN | claimed |
| US-8242130-B2 | Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases | RESVERLOGIX CORP. (CA) | 2012-08-14 | — | — | US | claimed |
| US-8093273-B2 | Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases | RESVERLOGIX CORP. (CA) | 2012-01-10 | — | — | US | claimed |
| EP-2332527-A2 | Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases | RESVERLOGIX CORP. (CA) | 2011-06-15 | — | — | EP | claimed |
| EP-1838296-A2 | FLAVANOIDS AND ISOFLAVANOIDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES | RESVERLOGIX CORP. (CA) | 2007-10-03 | — | — | EP | claimed |
| US-20060205767-A1 | Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases | HEPALINK (HONG KONG) LIMITED (HK) | 2006-09-14 | — | — | US | claimed |
| WO-2006045096-A2 | FLAVANOIDS AND ISOFLAVANOIDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES | RESVERLOGIX CORP. (CA) | 2006-04-27 | — | — | WO | claimed |
| US-12600116-B2 | Special polymer layers for faster laminability of multilayer structures | COVESTRO DEUTSCHLAND AG (DE) | 2026-04-14 | — | — | US | disclosed |
| US-3959353-A | Esters of hydroxyaryl adducts of decachloropentacyclo (5.3.0.02,6.04,10 05,9) decane-3-one | HOOKER CHEMICALS & PLASTICS CORPORATION (US) | 1976-05-25 | — | — | US | disclosed |
| US-3945959-A | ELECTRICAL INSULATION, CONDUCTORS | THE P. D. GEORGE CO. (US) | 1976-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060205767-A1 | Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases | APOB, APOL1, FABP3 | ESR1 357/4885ESR2 290/4885HSD17B1 448/4885 |
| US-12600116-B2 | Special polymer layers for faster laminability of multilayer structures | ASH2L, SMC2, ELL | ESR1 1394/4885ESR2 2120/4885HSD17B1 4596/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.